MRVI vs UTHR · rev $117.3M vs P/E 20, rev $1.56B
Maravai Lifesciences Holdings Inc (MRVI) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Maravai Lifesciences Holdings Inc (MRVI) is a biotechnology company listed on NASDAQ.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported MRVI revenue for 2026-06-30 was $117.3M. Net income was -$16.1M. Revenue was up 78.1% from 2026-03-31 to 2026-06-30. MRVI currently screens at market cap $1.93B.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
MRVI currently screens at market cap $1.93B. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the MRVI and UTHR stock pages for the full models.
Not investment advice.